PubMed:8043509
Annnotations
jnlpba-st-training
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 0-24 | protein | denotes | Corticosteroid receptors |
| T2 | 28-39 | cell_type | denotes | lymphocytes |
| T3 | 143-167 | protein | denotes | corticosteroid receptors |
| T4 | 235-259 | protein | denotes | corticosteroid receptors |
| T5 | 263-291 | cell_type | denotes | human mononuclear leukocytes |
| T6 | 334-365 | protein | denotes | Type I corticosteroid receptors |
| T7 | 531-563 | protein | denotes | Type II corticosteroid receptors |
| T8 | 729-735 | protein | denotes | Type I |
| T9 | 768-785 | protein | denotes | Type II receptors |
| T10 | 789-811 | cell_type | denotes | mononuclear leukocytes |
| T11 | 906-923 | protein | denotes | Type II receptors |
| T12 | 967-973 | protein | denotes | Type I |
| T13 | 981-998 | protein | denotes | Type II receptors |
| T14 | 1156-1199 | protein | denotes | Corticosteroid Type I and Type II receptors |
| T15 | 1285-1301 | protein | denotes | Type I receptors |
| T16 | 1352-1359 | protein | denotes | Type II |
| T17 | 1497-1521 | protein | denotes | corticosteroid receptors |
| T18 | 1575-1599 | protein | denotes | corticosteroid receptors |
pubmed-sentences-benchmark
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| S1 | 0-79 | Sentence | denotes | Corticosteroid receptors in lymphocytes: a possible marker of brain involution? |
| S2 | 80-200 | Sentence | denotes | A similarity has recently been found between the regulation of corticosteroid receptors in brain and in lymphoid tissue. |
| S3 | 201-333 | Sentence | denotes | We have studied the regulation of corticosteroid receptors in human mononuclear leukocytes as a possible marker of brain involution. |
| S4 | 334-530 | Sentence | denotes | Type I corticosteroid receptors are down regulated by excess of mineralocorticoids (primary and secondary hyperaldosteronism, pseudohyperaldosteronism) and of glucocorticoids (Cushing's syndrome). |
| S5 | 531-641 | Sentence | denotes | Type II corticosteroid receptors are not reduced by excess of endogenous corticosteroids (Cushing's syndrome). |
| S6 | 642-924 | Sentence | denotes | In normal adults there is a direct significant correlation between plasma cortisol and Type I and between plasma cortisol and Type II receptors in mononuclear leukocytes, while in Cushing's syndrome the correlation is inverse between plasma cortisol at 8 a.m. and Type II receptors. |
| S7 | 925-1155 | Sentence | denotes | In an aged population the mean numbers of Type I and of Type II receptors are lower and plasma cortisol is higher than in adult controls, but the increase of plasma cortisol is not followed by a clinical picture of hypercorticism. |
| S8 | 1156-1234 | Sentence | denotes | Corticosteroid Type I and Type II receptors are inversely correlated with age. |
| S9 | 1235-1379 | Sentence | denotes | After dexamethasone suppression (1 mg at 11 p.m.) Type I receptors always decrease in controls while the response of Type II is not homogeneous. |
| S10 | 1380-1454 | Sentence | denotes | In an aged group of patients, both receptors are reduced by dexamethasone. |
| S11 | 1455-1725 | Sentence | denotes | We conclude that the decrease with age of corticosteroid receptors is possibly related to a physiological involution of corticosteroid receptors and that this reduction does increase plasma cortisol concentration, without affecting the glucocorticoid effector mechanism. |
genia-medco-coref
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| C2 | 0-24 | NP | denotes | Corticosteroid receptors |
| C1 | 0-39 | NP | denotes | Corticosteroid receptors in lymphocytes |
| C3 | 62-78 | NP | denotes | brain involution |
| C4 | 143-167 | NP | denotes | corticosteroid receptors |
| C6 | 235-259 | NP | denotes | corticosteroid receptors |
| C5 | 235-291 | NP | denotes | corticosteroid receptors in human mononuclear leukocytes |
| C7 | 316-332 | NP | denotes | brain involution |
| C8 | 334-365 | NP | denotes | Type I corticosteroid receptors |
| C9 | 510-528 | NP | denotes | Cushing's syndrome |
| C10 | 531-563 | NP | denotes | Type II corticosteroid receptors |
| C11 | 621-639 | NP | denotes | Cushing's syndrome |
| C12 | 709-724 | NP | denotes | plasma cortisol |
| C13 | 729-735 | NP | denotes | Type I |
| C14 | 748-763 | NP | denotes | plasma cortisol |
| C15 | 768-811 | NP | denotes | Type II receptors in mononuclear leukocytes |
| C16 | 822-840 | NP | denotes | Cushing's syndrome |
| C17 | 876-891 | NP | denotes | plasma cortisol |
| C18 | 906-923 | NP | denotes | Type II receptors |
| C19 | 967-998 | NP | denotes | Type I and of Type II receptors |
| C20 | 1013-1028 | NP | denotes | plasma cortisol |
| C21 | 1047-1061 | NP | denotes | adult controls |
| C22 | 1083-1098 | NP | denotes | plasma cortisol |
| C23 | 1156-1199 | NP | denotes | Corticosteroid Type I and Type II receptors |
| C24 | 1285-1301 | NP | denotes | Type I receptors |
| C25 | 1321-1329 | NP | denotes | controls |
| C26 | 1352-1359 | NP | denotes | Type II |
| C27 | 1410-1424 | NP | denotes | both receptors |
| C29 | 1497-1521 | NP | denotes | corticosteroid receptors |
| C28 | 1472-1521 | NP | denotes | the decrease with age of corticosteroid receptors |
| C30 | 1575-1599 | NP | denotes | corticosteroid receptors |
| C31 | 1609-1623 | NP | denotes | this reduction |
| R1 | C4 | C2 | coref-ident | corticosteroid receptors,Corticosteroid receptors |
| R2 | C6 | C4 | coref-ident | corticosteroid receptors,corticosteroid receptors |
| R3 | C5 | C1 | coref-ident | corticosteroid receptors in human mononuclear leukocytes,Corticosteroid receptors in lymphocytes |
| R4 | C7 | C3 | coref-ident | brain involution,brain involution |
| R5 | C11 | C9 | coref-ident | Cushing's syndrome,Cushing's syndrome |
| R6 | C13 | C8 | coref-ident | Type I,Type I corticosteroid receptors |
| R7 | C14 | C12 | coref-ident | plasma cortisol,plasma cortisol |
| R8 | C15 | C10 | coref-ident | Type II receptors in mononuclear leukocytes,Type II corticosteroid receptors |
| R9 | C16 | C11 | coref-ident | Cushing's syndrome,Cushing's syndrome |
| R10 | C17 | C14 | coref-ident | plasma cortisol,plasma cortisol |
| R11 | C18 | C15 | coref-ident | Type II receptors,Type II receptors in mononuclear leukocytes |
| R12 | C20 | C17 | coref-ident | plasma cortisol,plasma cortisol |
| R13 | C22 | C20 | coref-ident | plasma cortisol,plasma cortisol |
| R14 | C23 | C19 | coref-ident | Corticosteroid Type I and Type II receptors,Type I and of Type II receptors |
| R15 | C24 | C13 | coref-ident | Type I receptors,Type I |
| R16 | C25 | C21 | coref-ident | controls,adult controls |
| R17 | C26 | C18 | coref-ident | Type II,Type II receptors |
| R18 | C27 | C23 | coref-ident | both receptors,Corticosteroid Type I and Type II receptors |
| R19 | C29 | C6 | coref-ident | corticosteroid receptors,corticosteroid receptors |
| R20 | C30 | C29 | coref-ident | corticosteroid receptors,corticosteroid receptors |
| R21 | C31 | C28 | coref-ident | this reduction,the decrease with age of corticosteroid receptors |
GENIAcorpus
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 0-24 | protein_family_or_group | denotes | Corticosteroid receptors |
| T2 | 28-39 | cell_type | denotes | lymphocytes |
| T3 | 62-78 | other_name | denotes | brain involution |
| T4 | 143-167 | protein_family_or_group | denotes | corticosteroid receptors |
| T5 | 171-176 | tissue | denotes | brain |
| T6 | 184-199 | tissue | denotes | lymphoid tissue |
| T7 | 235-259 | protein_family_or_group | denotes | corticosteroid receptors |
| T8 | 263-291 | cell_type | denotes | human mononuclear leukocytes |
| T9 | 316-332 | other_name | denotes | brain involution |
| T10 | 334-340 | protein_family_or_group | denotes | Type I |
| T11 | 341-365 | protein_family_or_group | denotes | corticosteroid receptors |
| T12 | 398-416 | lipid | denotes | mineralocorticoids |
| T13 | 440-458 | other_name | denotes | hyperaldosteronism |
| T14 | 460-484 | other_name | denotes | pseudohyperaldosteronism |
| T15 | 493-508 | lipid | denotes | glucocorticoids |
| T16 | 510-528 | other_name | denotes | Cushing's syndrome |
| T17 | 531-538 | protein_family_or_group | denotes | Type II |
| T18 | 539-563 | protein_family_or_group | denotes | corticosteroid receptors |
| T19 | 593-619 | lipid | denotes | endogenous corticosteroids |
| T20 | 621-639 | other_name | denotes | Cushing's syndrome |
| T21 | 709-724 | lipid | denotes | plasma cortisol |
| T22 | 729-735 | protein_family_or_group | denotes | Type I |
| T23 | 748-763 | lipid | denotes | plasma cortisol |
| T24 | 768-785 | protein_family_or_group | denotes | Type II receptors |
| T25 | 789-811 | cell_type | denotes | mononuclear leukocytes |
| T26 | 822-840 | other_name | denotes | Cushing's syndrome |
| T27 | 876-891 | lipid | denotes | plasma cortisol |
| T28 | 906-923 | protein_family_or_group | denotes | Type II receptors |
| T29 | 967-973 | protein_family_or_group | denotes | Type I |
| T30 | 981-998 | protein_family_or_group | denotes | Type II receptors |
| T31 | 1013-1028 | lipid | denotes | plasma cortisol |
| T32 | 1047-1061 | multi_cell | denotes | adult controls |
| T33 | 1083-1098 | lipid | denotes | plasma cortisol |
| T34 | 1140-1154 | other_name | denotes | hypercorticism |
| T35 | 1241-1254 | lipid | denotes | dexamethasone |
| T36 | 1285-1301 | protein_family_or_group | denotes | Type I receptors |
| T37 | 1352-1359 | protein_family_or_group | denotes | Type II |
| T38 | 1400-1408 | multi_cell | denotes | patients |
| T39 | 1440-1453 | lipid | denotes | dexamethasone |
| T40 | 1497-1521 | protein_family_or_group | denotes | corticosteroid receptors |
| T41 | 1575-1599 | protein_family_or_group | denotes | corticosteroid receptors |
| T42 | 1638-1653 | lipid | denotes | plasma cortisol |
| T43 | 1691-1705 | lipid | denotes | glucocorticoid |